- Home
- COLL vs NRDS Comparison
COLL vs NRDS Comparison
Compare COLL & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- NRDS
- Stock Information
- Founded
- COLL 2002
- NRDS 2009
- Country
- COLL United States
- NRDS United States
- Employees
- COLL N/A
- NRDS N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- NRDS EDP Services
- Sector
- COLL Health Care
- NRDS Technology
- Exchange
- COLL Nasdaq
- NRDS Nasdaq
- Market Cap
- COLL 1.0B
- NRDS 1.0B
- IPO Year
- COLL 2015
- NRDS 2021
- Fundamental
- Price
- COLL $29.13
- NRDS $10.33
- Analyst Decision
- COLL Strong Buy
- NRDS Buy
- Analyst Count
- COLL 5
- NRDS 5
- Target Price
- COLL $43.60
- NRDS $17.60
- AVG Volume (30 Days)
- COLL 294.2K
- NRDS 617.6K
- Earning Date
- COLL 02-27-2025
- NRDS 02-19-2025
- Dividend Yield
- COLL N/A
- NRDS N/A
- EPS Growth
- COLL 757.11
- NRDS N/A
- EPS
- COLL 2.16
- NRDS 0.38
- Revenue
- COLL $599,245,000.00
- NRDS $687,600,000.00
- Revenue This Year
- COLL $13.25
- NRDS $14.44
- Revenue Next Year
- COLL $17.67
- NRDS $13.10
- P/E Ratio
- COLL $13.47
- NRDS $27.42
- Revenue Growth
- COLL 9.62
- NRDS 14.71
- 52 Week Low
- COLL $28.39
- NRDS $10.10
- 52 Week High
- COLL $42.29
- NRDS $17.30
- Technical
- Relative Strength Index (RSI)
- COLL 37.61
- NRDS 21.71
- Support Level
- COLL $29.39
- NRDS $13.25
- Resistance Level
- COLL $30.39
- NRDS $14.45
- Average True Range (ATR)
- COLL 1.00
- NRDS 0.75
- MACD
- COLL -0.24
- NRDS -0.36
- Stochastic Oscillator
- COLL 11.04
- NRDS 3.38
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides onsumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. They get revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.